nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.725	1	CpDpCtD
L-DOPA—DRD5—eyelid—atopic dermatitis	0.0203	0.373	CbGeAlD
L-DOPA—SLC7A8—skin epidermis—atopic dermatitis	0.00762	0.14	CbGeAlD
L-DOPA—PSIP1—neck—atopic dermatitis	0.00554	0.102	CbGeAlD
L-DOPA—SLC7A8—neck—atopic dermatitis	0.00365	0.0671	CbGeAlD
L-DOPA—SLC7A8—skin of body—atopic dermatitis	0.00236	0.0434	CbGeAlD
L-DOPA—PSIP1—head—atopic dermatitis	0.00234	0.043	CbGeAlD
L-DOPA—SLC16A10—neck—atopic dermatitis	0.00217	0.0398	CbGeAlD
L-DOPA—SLC7A5—skin of body—atopic dermatitis	0.00183	0.0336	CbGeAlD
L-DOPA—SLC7A8—head—atopic dermatitis	0.00154	0.0283	CbGeAlD
L-DOPA—DRD3—head—atopic dermatitis	0.00137	0.0251	CbGeAlD
L-DOPA—DDC—head—atopic dermatitis	0.00133	0.0245	CbGeAlD
L-DOPA—DRD5—head—atopic dermatitis	0.00128	0.0236	CbGeAlD
L-DOPA—SLC7A5—head—atopic dermatitis	0.00119	0.0219	CbGeAlD
L-DOPA—SLC7A5—Sirolimus—Pimecrolimus—atopic dermatitis	0.00106	0.217	CbGdCrCtD
L-DOPA—SLC7A5—Sirolimus—Tacrolimus—atopic dermatitis	0.00106	0.217	CbGdCrCtD
L-DOPA—DRD1—head—atopic dermatitis	0.00098	0.018	CbGeAlD
L-DOPA—DRD2—head—atopic dermatitis	0.000579	0.0106	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Desonide—atopic dermatitis	0.000445	0.0915	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Fluocinonide—atopic dermatitis	0.000356	0.0733	CbGdCrCtD
L-DOPA—CYP2D6—head—atopic dermatitis	0.000348	0.00639	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Fluocinolone Acetonide—atopic dermatitis	0.000346	0.0712	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Mometasone—atopic dermatitis	0.000276	0.0568	CbGdCrCtD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000202	0.0416	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—atopic dermatitis	0.000175	0.036	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—atopic dermatitis	0.000165	0.0339	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—atopic dermatitis	0.000162	0.0334	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—atopic dermatitis	0.000162	0.0334	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—atopic dermatitis	0.000159	0.0326	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—atopic dermatitis	0.00015	0.031	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—atopic dermatitis	0.000147	0.0302	CbGdCrCtD
L-DOPA—Depression—Prednisone—atopic dermatitis	0.000135	0.000785	CcSEcCtD
L-DOPA—Mental disorder—Methylprednisolone—atopic dermatitis	0.000134	0.000782	CcSEcCtD
L-DOPA—Asthenia—Tacrolimus—atopic dermatitis	0.000134	0.000776	CcSEcCtD
L-DOPA—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000133	0.000776	CcSEcCtD
L-DOPA—Angioedema—Prednisolone—atopic dermatitis	0.000133	0.000774	CcSEcCtD
L-DOPA—Myocardial infarction—Prednisone—atopic dermatitis	0.000133	0.000772	CcSEcCtD
L-DOPA—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000133	0.000772	CcSEcCtD
L-DOPA—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000132	0.000767	CcSEcCtD
L-DOPA—Pruritus—Tacrolimus—atopic dermatitis	0.000132	0.000766	CcSEcCtD
L-DOPA—Malaise—Prednisolone—atopic dermatitis	0.000131	0.000764	CcSEcCtD
L-DOPA—Dysgeusia—Triamcinolone—atopic dermatitis	0.000131	0.000763	CcSEcCtD
L-DOPA—Syncope—Prednisolone—atopic dermatitis	0.000131	0.000759	CcSEcCtD
L-DOPA—Angioedema—Hydrocortisone—atopic dermatitis	0.00013	0.000756	CcSEcCtD
L-DOPA—Back pain—Triamcinolone—atopic dermatitis	0.00013	0.000753	CcSEcCtD
L-DOPA—Malaise—Hydrocortisone—atopic dermatitis	0.000128	0.000746	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisolone—atopic dermatitis	0.000128	0.000744	CcSEcCtD
L-DOPA—Syncope—Hydrocortisone—atopic dermatitis	0.000128	0.000742	CcSEcCtD
L-DOPA—Diarrhoea—Tacrolimus—atopic dermatitis	0.000127	0.00074	CcSEcCtD
L-DOPA—Convulsion—Prednisolone—atopic dermatitis	0.000126	0.000734	CcSEcCtD
L-DOPA—Hypertension—Prednisolone—atopic dermatitis	0.000126	0.000731	CcSEcCtD
L-DOPA—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000125	0.000727	CcSEcCtD
L-DOPA—Arrhythmia—Dexamethasone—atopic dermatitis	0.000125	0.000725	CcSEcCtD
L-DOPA—Arrhythmia—Betamethasone—atopic dermatitis	0.000125	0.000725	CcSEcCtD
L-DOPA—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000124	0.000723	CcSEcCtD
L-DOPA—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000124	0.000721	CcSEcCtD
L-DOPA—Alopecia—Betamethasone—atopic dermatitis	0.000123	0.000717	CcSEcCtD
L-DOPA—Alopecia—Dexamethasone—atopic dermatitis	0.000123	0.000717	CcSEcCtD
L-DOPA—Convulsion—Hydrocortisone—atopic dermatitis	0.000123	0.000717	CcSEcCtD
L-DOPA—Dizziness—Tacrolimus—atopic dermatitis	0.000123	0.000716	CcSEcCtD
L-DOPA—Hypertension—Hydrocortisone—atopic dermatitis	0.000123	0.000714	CcSEcCtD
L-DOPA—Discomfort—Prednisolone—atopic dermatitis	0.000123	0.000712	CcSEcCtD
L-DOPA—Angioedema—Triamcinolone—atopic dermatitis	0.000122	0.000712	CcSEcCtD
L-DOPA—Haemoglobin—Prednisone—atopic dermatitis	0.000122	0.000711	CcSEcCtD
L-DOPA—Angioedema—Methylprednisolone—atopic dermatitis	0.000122	0.00071	CcSEcCtD
L-DOPA—Haemorrhage—Prednisone—atopic dermatitis	0.000122	0.000707	CcSEcCtD
L-DOPA—Hallucination—Prednisone—atopic dermatitis	0.000121	0.000703	CcSEcCtD
L-DOPA—Malaise—Triamcinolone—atopic dermatitis	0.000121	0.000702	CcSEcCtD
L-DOPA—Anxiety—Hydrocortisone—atopic dermatitis	0.000121	0.000702	CcSEcCtD
L-DOPA—Malaise—Methylprednisolone—atopic dermatitis	0.000121	0.000701	CcSEcCtD
L-DOPA—Syncope—Triamcinolone—atopic dermatitis	0.00012	0.000698	CcSEcCtD
L-DOPA—Syncope—Methylprednisolone—atopic dermatitis	0.00012	0.000697	CcSEcCtD
L-DOPA—Discomfort—Hydrocortisone—atopic dermatitis	0.00012	0.000696	CcSEcCtD
L-DOPA—Oedema—Prednisolone—atopic dermatitis	0.000119	0.000691	CcSEcCtD
L-DOPA—Vomiting—Tacrolimus—atopic dermatitis	0.000118	0.000688	CcSEcCtD
L-DOPA—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000118	0.000685	CcSEcCtD
L-DOPA—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000117	0.000683	CcSEcCtD
L-DOPA—Rash—Tacrolimus—atopic dermatitis	0.000117	0.000682	CcSEcCtD
L-DOPA—Dermatitis—Tacrolimus—atopic dermatitis	0.000117	0.000682	CcSEcCtD
L-DOPA—Shock—Prednisolone—atopic dermatitis	0.000117	0.00068	CcSEcCtD
L-DOPA—Cough—Triamcinolone—atopic dermatitis	0.000117	0.00068	CcSEcCtD
L-DOPA—Headache—Tacrolimus—atopic dermatitis	0.000117	0.000678	CcSEcCtD
L-DOPA—Oedema—Hydrocortisone—atopic dermatitis	0.000116	0.000675	CcSEcCtD
L-DOPA—Convulsion—Triamcinolone—atopic dermatitis	0.000116	0.000675	CcSEcCtD
L-DOPA—Convulsion—Methylprednisolone—atopic dermatitis	0.000116	0.000673	CcSEcCtD
L-DOPA—Hypertension—Triamcinolone—atopic dermatitis	0.000116	0.000672	CcSEcCtD
L-DOPA—Hypertension—Methylprednisolone—atopic dermatitis	0.000115	0.000671	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000115	0.000668	CcSEcCtD
L-DOPA—Shock—Hydrocortisone—atopic dermatitis	0.000114	0.000664	CcSEcCtD
L-DOPA—Anxiety—Methylprednisolone—atopic dermatitis	0.000113	0.000659	CcSEcCtD
L-DOPA—Flushing—Prednisone—atopic dermatitis	0.000113	0.000656	CcSEcCtD
L-DOPA—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000113	0.000656	CcSEcCtD
L-DOPA—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000113	0.000656	CcSEcCtD
L-DOPA—Discomfort—Triamcinolone—atopic dermatitis	0.000113	0.000655	CcSEcCtD
L-DOPA—Discomfort—Methylprednisolone—atopic dermatitis	0.000112	0.000654	CcSEcCtD
L-DOPA—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000112	0.000653	CcSEcCtD
L-DOPA—Dry mouth—Triamcinolone—atopic dermatitis	0.000112	0.000648	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—atopic dermatitis	0.000111	0.000646	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—atopic dermatitis	0.000111	0.000646	CcSEcCtD
L-DOPA—Anorexia—Hydrocortisone—atopic dermatitis	0.000111	0.000643	CcSEcCtD
L-DOPA—Nausea—Tacrolimus—atopic dermatitis	0.000111	0.000643	CcSEcCtD
L-DOPA—Confusional state—Methylprednisolone—atopic dermatitis	0.00011	0.000639	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—atopic dermatitis	0.00011	0.000637	CcSEcCtD
L-DOPA—Malaise—Betamethasone—atopic dermatitis	0.00011	0.000637	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—atopic dermatitis	0.000109	0.000636	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—atopic dermatitis	0.000109	0.000634	CcSEcCtD
L-DOPA—Syncope—Betamethasone—atopic dermatitis	0.000109	0.000634	CcSEcCtD
L-DOPA—Arrhythmia—Prednisone—atopic dermatitis	0.000109	0.000632	CcSEcCtD
L-DOPA—Hypotension—Hydrocortisone—atopic dermatitis	0.000108	0.000631	CcSEcCtD
L-DOPA—Shock—Triamcinolone—atopic dermatitis	0.000108	0.000625	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—atopic dermatitis	0.000108	0.000625	CcSEcCtD
L-DOPA—Alopecia—Prednisone—atopic dermatitis	0.000107	0.000625	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—atopic dermatitis	0.000107	0.000624	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—atopic dermatitis	0.000107	0.000621	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000107	0.000621	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—atopic dermatitis	0.000107	0.000621	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—atopic dermatitis	0.000107	0.000619	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000106	0.000614	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000105	0.000613	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—atopic dermatitis	0.000105	0.000612	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—atopic dermatitis	0.000105	0.000612	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—atopic dermatitis	0.000105	0.000611	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—atopic dermatitis	0.000105	0.00061	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—atopic dermatitis	0.000105	0.00061	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000104	0.000606	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—atopic dermatitis	0.000103	0.0006	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—atopic dermatitis	0.000103	0.0006	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—atopic dermatitis	0.000102	0.000594	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—atopic dermatitis	0.000102	0.000594	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000102	0.000594	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—atopic dermatitis	0.000102	0.000593	CcSEcCtD
L-DOPA—Pain—Prednisolone—atopic dermatitis	0.000102	0.000591	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000101	0.000587	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.0001	0.000583	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—atopic dermatitis	0.0001	0.000582	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—atopic dermatitis	9.97e-05	0.00058	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—atopic dermatitis	9.93e-05	0.000577	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—atopic dermatitis	9.92e-05	0.000577	CcSEcCtD
L-DOPA—Oedema—Betamethasone—atopic dermatitis	9.92e-05	0.000577	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—atopic dermatitis	9.89e-05	0.000575	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—atopic dermatitis	9.86e-05	0.000574	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—atopic dermatitis	9.82e-05	0.000571	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—atopic dermatitis	9.81e-05	0.000571	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—atopic dermatitis	9.79e-05	0.00057	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—atopic dermatitis	9.79e-05	0.000569	CcSEcCtD
L-DOPA—Anaemia—Prednisone—atopic dermatitis	9.78e-05	0.000569	CcSEcCtD
L-DOPA—Shock—Betamethasone—atopic dermatitis	9.76e-05	0.000567	CcSEcCtD
L-DOPA—Shock—Dexamethasone—atopic dermatitis	9.76e-05	0.000567	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—atopic dermatitis	9.74e-05	0.000567	CcSEcCtD
L-DOPA—Agitation—Prednisone—atopic dermatitis	9.73e-05	0.000566	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—atopic dermatitis	9.71e-05	0.000565	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.71e-05	0.000565	CcSEcCtD
L-DOPA—Angioedema—Prednisone—atopic dermatitis	9.67e-05	0.000562	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—atopic dermatitis	9.62e-05	0.00056	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—atopic dermatitis	9.6e-05	0.000558	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—atopic dermatitis	9.59e-05	0.000558	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.59e-05	0.000558	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.57e-05	0.000556	CcSEcCtD
L-DOPA—Malaise—Prednisone—atopic dermatitis	9.54e-05	0.000555	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.49e-05	0.000552	CcSEcCtD
L-DOPA—Syncope—Prednisone—atopic dermatitis	9.49e-05	0.000552	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—atopic dermatitis	9.45e-05	0.00055	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—atopic dermatitis	9.45e-05	0.00055	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—atopic dermatitis	9.44e-05	0.000549	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—atopic dermatitis	9.42e-05	0.000548	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—atopic dermatitis	9.4e-05	0.000547	CcSEcCtD
L-DOPA—Pain—Triamcinolone—atopic dermatitis	9.35e-05	0.000544	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—atopic dermatitis	9.3e-05	0.000541	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—atopic dermatitis	9.27e-05	0.000539	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—atopic dermatitis	9.27e-05	0.000539	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—atopic dermatitis	9.22e-05	0.000536	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—atopic dermatitis	9.18e-05	0.000534	CcSEcCtD
L-DOPA—Convulsion—Prednisone—atopic dermatitis	9.17e-05	0.000533	CcSEcCtD
L-DOPA—Hypertension—Prednisone—atopic dermatitis	9.14e-05	0.000531	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—atopic dermatitis	9.01e-05	0.000524	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.99e-05	0.000523	CcSEcCtD
L-DOPA—Anxiety—Prednisone—atopic dermatitis	8.98e-05	0.000522	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—atopic dermatitis	8.97e-05	0.000522	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—atopic dermatitis	8.97e-05	0.000522	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.92e-05	0.000519	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—atopic dermatitis	8.91e-05	0.000518	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—atopic dermatitis	8.91e-05	0.000518	CcSEcCtD
L-DOPA—Discomfort—Prednisone—atopic dermatitis	8.9e-05	0.000518	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—atopic dermatitis	8.76e-05	0.000509	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—atopic dermatitis	8.73e-05	0.000508	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—atopic dermatitis	8.73e-05	0.000508	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—atopic dermatitis	8.68e-05	0.000505	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—atopic dermatitis	8.66e-05	0.000504	CcSEcCtD
L-DOPA—Oedema—Prednisone—atopic dermatitis	8.64e-05	0.000502	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—atopic dermatitis	8.62e-05	0.000501	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—atopic dermatitis	8.62e-05	0.000501	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—atopic dermatitis	8.62e-05	0.000501	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.56e-05	0.000498	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.56e-05	0.000498	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.55e-05	0.000497	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—atopic dermatitis	8.55e-05	0.000497	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—atopic dermatitis	8.55e-05	0.000497	CcSEcCtD
L-DOPA—Shock—Prednisone—atopic dermatitis	8.5e-05	0.000494	CcSEcCtD
L-DOPA—Pain—Betamethasone—atopic dermatitis	8.48e-05	0.000493	CcSEcCtD
L-DOPA—Pain—Dexamethasone—atopic dermatitis	8.48e-05	0.000493	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—atopic dermatitis	8.35e-05	0.000486	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—atopic dermatitis	8.33e-05	0.000484	CcSEcCtD
L-DOPA—Anorexia—Prednisone—atopic dermatitis	8.23e-05	0.000479	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—atopic dermatitis	8.21e-05	0.000478	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—atopic dermatitis	8.17e-05	0.000475	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—atopic dermatitis	8.17e-05	0.000475	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.11e-05	0.000472	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.11e-05	0.000472	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—atopic dermatitis	8.05e-05	0.000468	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.04e-05	0.000467	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—atopic dermatitis	7.94e-05	0.000462	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—atopic dermatitis	7.88e-05	0.000458	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—atopic dermatitis	7.88e-05	0.000458	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—atopic dermatitis	7.86e-05	0.000457	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—atopic dermatitis	7.84e-05	0.000456	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—atopic dermatitis	7.84e-05	0.000456	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—atopic dermatitis	7.84e-05	0.000456	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—atopic dermatitis	7.82e-05	0.000455	CcSEcCtD
L-DOPA—Insomnia—Prednisone—atopic dermatitis	7.81e-05	0.000454	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—atopic dermatitis	7.76e-05	0.000451	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—atopic dermatitis	7.73e-05	0.00045	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—atopic dermatitis	7.72e-05	0.000449	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—atopic dermatitis	7.68e-05	0.000446	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—atopic dermatitis	7.6e-05	0.000442	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—atopic dermatitis	7.51e-05	0.000437	CcSEcCtD
L-DOPA—Rash—Prednisolone—atopic dermatitis	7.49e-05	0.000436	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—atopic dermatitis	7.49e-05	0.000435	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—atopic dermatitis	7.46e-05	0.000434	CcSEcCtD
L-DOPA—Fatigue—Prednisone—atopic dermatitis	7.45e-05	0.000433	CcSEcCtD
L-DOPA—Headache—Prednisolone—atopic dermatitis	7.45e-05	0.000433	CcSEcCtD
L-DOPA—Constipation—Prednisone—atopic dermatitis	7.39e-05	0.00043	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—atopic dermatitis	7.38e-05	0.000429	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—atopic dermatitis	7.32e-05	0.000426	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—atopic dermatitis	7.31e-05	0.000425	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—atopic dermatitis	7.27e-05	0.000423	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—atopic dermatitis	7.23e-05	0.00042	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—atopic dermatitis	7.21e-05	0.000419	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—atopic dermatitis	7.12e-05	0.000414	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—atopic dermatitis	7.12e-05	0.000414	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—atopic dermatitis	7.12e-05	0.000414	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—atopic dermatitis	7.06e-05	0.000411	CcSEcCtD
L-DOPA—Nausea—Prednisolone—atopic dermatitis	7.06e-05	0.000411	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—atopic dermatitis	7.02e-05	0.000408	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—atopic dermatitis	7.02e-05	0.000408	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—atopic dermatitis	6.95e-05	0.000404	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—atopic dermatitis	6.93e-05	0.000403	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—atopic dermatitis	6.9e-05	0.000401	CcSEcCtD
L-DOPA—Rash—Triamcinolone—atopic dermatitis	6.89e-05	0.000401	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—atopic dermatitis	6.89e-05	0.0004	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—atopic dermatitis	6.88e-05	0.0004	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—atopic dermatitis	6.87e-05	0.0004	CcSEcCtD
L-DOPA—Urticaria—Prednisone—atopic dermatitis	6.86e-05	0.000399	CcSEcCtD
L-DOPA—Headache—Triamcinolone—atopic dermatitis	6.85e-05	0.000398	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—atopic dermatitis	6.83e-05	0.000397	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—atopic dermatitis	6.83e-05	0.000397	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—atopic dermatitis	6.79e-05	0.000395	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—atopic dermatitis	6.79e-05	0.000395	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—atopic dermatitis	6.56e-05	0.000381	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—atopic dermatitis	6.56e-05	0.000381	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—atopic dermatitis	6.49e-05	0.000378	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—atopic dermatitis	6.48e-05	0.000377	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—atopic dermatitis	6.36e-05	0.00037	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—atopic dermatitis	6.31e-05	0.000367	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—atopic dermatitis	6.31e-05	0.000367	CcSEcCtD
L-DOPA—Rash—Dexamethasone—atopic dermatitis	6.25e-05	0.000364	CcSEcCtD
L-DOPA—Rash—Betamethasone—atopic dermatitis	6.25e-05	0.000364	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—atopic dermatitis	6.25e-05	0.000363	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—atopic dermatitis	6.25e-05	0.000363	CcSEcCtD
L-DOPA—Headache—Betamethasone—atopic dermatitis	6.21e-05	0.000361	CcSEcCtD
L-DOPA—Headache—Dexamethasone—atopic dermatitis	6.21e-05	0.000361	CcSEcCtD
L-DOPA—Asthenia—Prednisone—atopic dermatitis	6.2e-05	0.00036	CcSEcCtD
L-DOPA—Pruritus—Prednisone—atopic dermatitis	6.11e-05	0.000355	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—atopic dermatitis	5.91e-05	0.000344	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—atopic dermatitis	5.89e-05	0.000343	CcSEcCtD
L-DOPA—Nausea—Betamethasone—atopic dermatitis	5.89e-05	0.000343	CcSEcCtD
L-DOPA—Dizziness—Prednisone—atopic dermatitis	5.71e-05	0.000332	CcSEcCtD
L-DOPA—Vomiting—Prednisone—atopic dermatitis	5.49e-05	0.000319	CcSEcCtD
L-DOPA—Rash—Prednisone—atopic dermatitis	5.45e-05	0.000317	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—atopic dermatitis	5.44e-05	0.000316	CcSEcCtD
L-DOPA—Headache—Prednisone—atopic dermatitis	5.41e-05	0.000315	CcSEcCtD
L-DOPA—Nausea—Prednisone—atopic dermatitis	5.13e-05	0.000298	CcSEcCtD
L-DOPA—DRD4—GPCR ligand binding—CCL5—atopic dermatitis	5.01e-05	0.00115	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCR3—atopic dermatitis	5.01e-05	0.00115	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TAC1—atopic dermatitis	4.99e-05	0.00115	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—NPS—atopic dermatitis	4.99e-05	0.00115	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—IL6—atopic dermatitis	4.95e-05	0.00114	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCR3—atopic dermatitis	4.89e-05	0.00113	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL27—atopic dermatitis	4.87e-05	0.00112	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.85e-05	0.00112	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL22—atopic dermatitis	4.75e-05	0.0011	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL5—atopic dermatitis	4.75e-05	0.00109	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	4.7e-05	0.00108	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL11—atopic dermatitis	4.67e-05	0.00108	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCR3—atopic dermatitis	4.65e-05	0.00107	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL11—atopic dermatitis	4.61e-05	0.00106	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FCER2—atopic dermatitis	4.6e-05	0.00106	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—KIF3A—atopic dermatitis	4.59e-05	0.00106	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FCER2—atopic dermatitis	4.54e-05	0.00105	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CCR5—atopic dermatitis	4.51e-05	0.00104	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CCL5—atopic dermatitis	4.51e-05	0.00104	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.51e-05	0.00104	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—MAPK8—atopic dermatitis	4.49e-05	0.00104	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.47e-05	0.00103	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCL10—atopic dermatitis	4.46e-05	0.00103	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CCL5—atopic dermatitis	4.45e-05	0.00103	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL17—atopic dermatitis	4.37e-05	0.00101	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL22—atopic dermatitis	4.28e-05	0.000986	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL27—atopic dermatitis	4.24e-05	0.000976	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCR3—atopic dermatitis	4.23e-05	0.000974	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL22—atopic dermatitis	4.22e-05	0.000973	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCR3—atopic dermatitis	4.19e-05	0.000966	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.17e-05	0.000961	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CMA1—atopic dermatitis	4.15e-05	0.000956	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL11—atopic dermatitis	4.15e-05	0.000956	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TAC1—atopic dermatitis	4.15e-05	0.000956	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—NPS—atopic dermatitis	4.15e-05	0.000956	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCR3—atopic dermatitis	4.13e-05	0.000953	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCR3—atopic dermatitis	4.07e-05	0.000938	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CCR5—atopic dermatitis	4.06e-05	0.000936	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL10—atopic dermatitis	4.05e-05	0.000933	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—MAPK8—atopic dermatitis	4.04e-05	0.000932	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.03e-05	0.000928	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CCR5—atopic dermatitis	4.01e-05	0.000924	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—CXCL8—atopic dermatitis	4e-05	0.000922	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—MAPK8—atopic dermatitis	3.99e-05	0.00092	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL10—atopic dermatitis	3.96e-05	0.000912	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—STAT6—atopic dermatitis	3.9e-05	0.000899	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL5—atopic dermatitis	3.86e-05	0.000889	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CCL5—atopic dermatitis	3.84e-05	0.000884	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL27—atopic dermatitis	3.81e-05	0.000879	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCR3—atopic dermatitis	3.81e-05	0.000877	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL17—atopic dermatitis	3.8e-05	0.000876	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TAC1—atopic dermatitis	3.77e-05	0.000868	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—NPS—atopic dermatitis	3.77e-05	0.000868	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL27—atopic dermatitis	3.76e-05	0.000867	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCR3—atopic dermatitis	3.75e-05	0.000865	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TAC1—atopic dermatitis	3.74e-05	0.000861	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—NPS—atopic dermatitis	3.74e-05	0.000861	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CXCL8—atopic dermatitis	3.7e-05	0.000852	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCR3—atopic dermatitis	3.69e-05	0.000851	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TAC1—atopic dermatitis	3.69e-05	0.000849	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—NPS—atopic dermatitis	3.69e-05	0.000849	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.66e-05	0.000844	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCR3—atopic dermatitis	3.61e-05	0.000833	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.58e-05	0.000826	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL11—atopic dermatitis	3.52e-05	0.000812	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL5—atopic dermatitis	3.5e-05	0.000807	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCL5—atopic dermatitis	3.48e-05	0.000803	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FCER2—atopic dermatitis	3.48e-05	0.000801	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL5—atopic dermatitis	3.47e-05	0.0008	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CCR5—atopic dermatitis	3.46e-05	0.000796	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL5—atopic dermatitis	3.43e-05	0.00079	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL17—atopic dermatitis	3.42e-05	0.000788	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCL5—atopic dermatitis	3.4e-05	0.000785	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TAC1—atopic dermatitis	3.39e-05	0.000782	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—NPS—atopic dermatitis	3.39e-05	0.000782	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—KIF3A—atopic dermatitis	3.39e-05	0.000781	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR3—atopic dermatitis	3.38e-05	0.00078	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL17—atopic dermatitis	3.38e-05	0.000778	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—NPS—atopic dermatitis	3.35e-05	0.000771	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TAC1—atopic dermatitis	3.35e-05	0.000771	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCR3—atopic dermatitis	3.33e-05	0.000767	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL10—atopic dermatitis	3.29e-05	0.000758	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCR3—atopic dermatitis	3.28e-05	0.000756	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL22—atopic dermatitis	3.23e-05	0.000745	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.23e-05	0.000743	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.18e-05	0.000733	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR3—atopic dermatitis	3.16e-05	0.000729	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL5—atopic dermatitis	3.15e-05	0.000727	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCR5—atopic dermatitis	3.14e-05	0.000723	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL5—atopic dermatitis	3.11e-05	0.000717	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCR5—atopic dermatitis	3.07e-05	0.000707	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL11—atopic dermatitis	3.06e-05	0.000706	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CMA1—atopic dermatitis	3.06e-05	0.000706	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.06e-05	0.000706	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	3.05e-05	0.000704	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—KIF3A—atopic dermatitis	3.05e-05	0.000703	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NPS—atopic dermatitis	3.02e-05	0.000695	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TAC1—atopic dermatitis	3.02e-05	0.000695	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—KIF3A—atopic dermatitis	3.01e-05	0.000693	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL10—atopic dermatitis	2.99e-05	0.000688	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.96e-05	0.000682	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCR3—atopic dermatitis	2.96e-05	0.000682	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.92e-05	0.000673	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—STAT6—atopic dermatitis	2.88e-05	0.000664	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL27—atopic dermatitis	2.88e-05	0.000664	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	2.87e-05	0.000662	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—atopic dermatitis	2.87e-05	0.000661	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCL5—atopic dermatitis	2.83e-05	0.000652	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	2.82e-05	0.00065	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	2.82e-05	0.00065	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—atopic dermatitis	2.81e-05	0.000648	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL5—atopic dermatitis	2.8e-05	0.000646	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.77e-05	0.000637	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CMA1—atopic dermatitis	2.76e-05	0.000635	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL11—atopic dermatitis	2.76e-05	0.000635	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CXCL8—atopic dermatitis	2.73e-05	0.000629	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CMA1—atopic dermatitis	2.72e-05	0.000627	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL11—atopic dermatitis	2.72e-05	0.000627	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PPARA—atopic dermatitis	2.7e-05	0.000623	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL10—atopic dermatitis	2.69e-05	0.00062	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL10—atopic dermatitis	2.65e-05	0.000611	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	2.62e-05	0.000604	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—STAT6—atopic dermatitis	2.59e-05	0.000597	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL17—atopic dermatitis	2.58e-05	0.000595	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—atopic dermatitis	2.58e-05	0.000595	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCL5—atopic dermatitis	2.57e-05	0.000592	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	2.56e-05	0.00059	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—NPS—atopic dermatitis	2.56e-05	0.00059	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—STAT6—atopic dermatitis	2.56e-05	0.00059	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCR5—atopic dermatitis	2.55e-05	0.000588	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCL5—atopic dermatitis	2.55e-05	0.000587	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—atopic dermatitis	2.55e-05	0.000587	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCL5—atopic dermatitis	2.51e-05	0.000579	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	2.51e-05	0.000579	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR3—atopic dermatitis	2.5e-05	0.000575	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CXCL8—atopic dermatitis	2.46e-05	0.000566	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.44e-05	0.000561	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CXCL8—atopic dermatitis	2.42e-05	0.000559	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL10—atopic dermatitis	2.39e-05	0.000551	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL5—atopic dermatitis	2.38e-05	0.000549	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCR5—atopic dermatitis	2.32e-05	0.000534	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	2.31e-05	0.000533	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	2.3e-05	0.000531	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	2.3e-05	0.000529	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL5—atopic dermatitis	2.28e-05	0.000526	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCR5—atopic dermatitis	2.27e-05	0.000522	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR3—atopic dermatitis	2.25e-05	0.000518	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.24e-05	0.000515	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TAC1—atopic dermatitis	2.23e-05	0.000513	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPS—atopic dermatitis	2.23e-05	0.000513	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR3—atopic dermatitis	2.22e-05	0.000511	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCR3—atopic dermatitis	2.18e-05	0.000503	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CXCL8—atopic dermatitis	2.09e-05	0.000481	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	2.09e-05	0.00048	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CMA1—atopic dermatitis	2.08e-05	0.00048	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL11—atopic dermatitis	2.08e-05	0.00048	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL5—atopic dermatitis	2.07e-05	0.000477	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL5—atopic dermatitis	2.06e-05	0.000474	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCR5—atopic dermatitis	2.06e-05	0.000474	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	2.03e-05	0.000468	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TAC1—atopic dermatitis	2e-05	0.000462	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPS—atopic dermatitis	2e-05	0.000462	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—atopic dermatitis	2e-05	0.00046	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TAC1—atopic dermatitis	1.98e-05	0.000456	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPS—atopic dermatitis	1.98e-05	0.000456	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	1.96e-05	0.000453	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—STAT6—atopic dermatitis	1.96e-05	0.000451	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	1.95e-05	0.000449	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCR3—atopic dermatitis	1.94e-05	0.000447	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	1.92e-05	0.000443	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.92e-05	0.000442	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NGF—atopic dermatitis	1.91e-05	0.000439	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL8—atopic dermatitis	1.9e-05	0.000437	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL5—atopic dermatitis	1.86e-05	0.000429	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	1.85e-05	0.000427	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR5—atopic dermatitis	1.85e-05	0.000427	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL5—atopic dermatitis	1.84e-05	0.000424	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.84e-05	0.000423	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—atopic dermatitis	1.81e-05	0.000418	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL10—atopic dermatitis	1.76e-05	0.000407	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	1.75e-05	0.000403	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	1.73e-05	0.000399	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.7e-05	0.000391	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	1.59e-05	0.000366	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.57e-05	0.000363	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFKBIA—atopic dermatitis	1.57e-05	0.000362	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.57e-05	0.000361	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.54e-05	0.000355	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL5—atopic dermatitis	1.52e-05	0.00035	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.51e-05	0.000349	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.51e-05	0.000349	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.48e-05	0.000342	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	1.47e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NGF—atopic dermatitis	1.41e-05	0.000324	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.41e-05	0.000324	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	1.4e-05	0.000323	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.39e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.37e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR5—atopic dermatitis	1.37e-05	0.000315	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.37e-05	0.000315	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL5—atopic dermatitis	1.35e-05	0.000311	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—atopic dermatitis	1.34e-05	0.000308	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.33e-05	0.000306	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	1.31e-05	0.000302	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.27e-05	0.000292	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.00029	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NGF—atopic dermatitis	1.25e-05	0.000288	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	1.24e-05	0.000287	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.23e-05	0.000284	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR5—atopic dermatitis	1.22e-05	0.00028	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.2e-05	0.000278	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.2e-05	0.000276	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—atopic dermatitis	1.19e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	1.16e-05	0.000267	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	1.12e-05	0.000258	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—atopic dermatitis	1.07e-05	0.000247	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—atopic dermatitis	1.07e-05	0.000246	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.05e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.04e-05	0.000241	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL5—atopic dermatitis	1.03e-05	0.000238	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	0.000237	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	1e-05	0.000231	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	9.86e-06	0.000227	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NGF—atopic dermatitis	9.56e-06	0.00022	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	9.52e-06	0.000219	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—atopic dermatitis	9.3e-06	0.000214	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—atopic dermatitis	9.1e-06	0.00021	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	8.27e-06	0.000191	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—atopic dermatitis	7.91e-06	0.000182	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	7.88e-06	0.000182	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—atopic dermatitis	7.87e-06	0.000181	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	7.45e-06	0.000172	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	7.35e-06	0.000169	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	7.28e-06	0.000168	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—atopic dermatitis	7.12e-06	0.000164	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—atopic dermatitis	7.08e-06	0.000163	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—atopic dermatitis	7.02e-06	0.000162	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—atopic dermatitis	6.99e-06	0.000161	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	6.55e-06	0.000151	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	6.46e-06	0.000149	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—atopic dermatitis	6.3e-06	0.000145	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.22e-06	0.000143	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	5.62e-06	0.00013	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—atopic dermatitis	5.37e-06	0.000124	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—atopic dermatitis	5.35e-06	0.000123	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	4.95e-06	0.000114	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—atopic dermatitis	4.65e-06	0.000107	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—atopic dermatitis	4.18e-06	9.64e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—atopic dermatitis	4.13e-06	9.51e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—atopic dermatitis	3.16e-06	7.28e-05	CbGpPWpGaD
